Takeda Pharmaceutical Co. Ltd. has announced an agreement with Research Foundation for Microbial Diseases (BIKEN), of Osaka University, to sell the latter's live attenuated varicella (chickenpox) vaccine. The product will be launched in February; no financial details pertaining to the deal were disclosed.